Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Van Hemelrijck, Mieke"'
Autor:
Lin E; School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), King's College London, London, United Kingdom., Garmo H; School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), King's College London, London, United Kingdom.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Van Hemelrijck M; School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), King's College London, London, United Kingdom., Zethelius B; Department of Public Health/Geriatrics, Uppsala University, Uppsala, Sweden., Stattin P; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Hagström E; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.; Uppsala Clinical Research Centre, Uppsala, Sweden., Adolfsson J; Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden., Crawley D; School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), King's College London, London, United Kingdom.
Publikováno v:
JAMA network open [JAMA Netw Open] 2022 Aug 01; Vol. 5 (8), pp. e2225600. Date of Electronic Publication: 2022 Aug 01.
Autor:
George G; King's College London, Translational Oncology and Urology Research, London, UK., Garmo H; King's College London, Translational Oncology and Urology Research, London, UK., Scailteux LM; University of Rennes, EA 7449 REPERES Pharmacoepidemiology and Health Services Research, Rennes, France.; Rennes Hospital University, Pharmacovigilance Pharmacoepidemiology and Drug Information Center, Rennes, France., Balusson F; University of Rennes, EA 7449 REPERES Pharmacoepidemiology and Health Services Research, Rennes, France., De Coster G; Belgian Cancer Registry, Brussels, Belgium., De Schutter H; Belgian Cancer Registry, Brussels, Belgium., Kuiper JG; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Oger E; Rennes Hospital University, Pharmacovigilance Pharmacoepidemiology and Drug Information Center, Rennes, France., Verbeeck J; Belgian Cancer Registry, Brussels, Belgium., Van Hemelrijck M; King's College London, Translational Oncology and Urology Research, London, UK.
Publikováno v:
International journal of cancer [Int J Cancer] 2021 May 01; Vol. 148 (9), pp. 2203-2211. Date of Electronic Publication: 2020 Nov 23.
Autor:
George G; Translational Oncology and Urology Research, King's College Londo, London, UK., Vikman H; Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden., Gedeborg R; Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden., Lissbrant IF; Institute of Clinical Sciences, Department of Oncology, Sahlgrenska Academy, University of Göteborg, Göteborg, Sweden., Garmo H; Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden.; Regional Cancer Centre Uppsala Örebro, Uppsala University Hospital, Uppsala, Sweden., Styrke J; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden., Van Hemelrijck M; Translational Oncology and Urology Research, King's College Londo, London, UK., Stattin P; Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2021 Apr; Vol. 60 (4), pp. 459-465. Date of Electronic Publication: 2021 Feb 19.
Autor:
George G; Translational Oncology and Urology Research, King's College London, London, UK., Scailteux LM; Pharmacovigilance, Pharmacoepidemiology and Drug Information Center, Rennes Hospital University, Rennes, France.; REPERES (Pharmacoepidemiology and Heath Services Research), Rennes University, EA 7449, F-35000, Rennes, France., Garmo H; Translational Oncology and Urology Research, King's College London, London, UK., Balusson F; REPERES (Pharmacoepidemiology and Heath Services Research), Rennes University, EA 7449, F-35000, Rennes, France., Cardwell C; Centre for Public Health, Institute for Health Sciences, Queen's University Belfast, Belfast, Northern Ireland., Coster G; Belgian Cancer Registry, Brussels, Belgium., Schutter H; Belgian Cancer Registry, Brussels, Belgium., Kuiper JG; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., McMenamin Ú; Centre for Public Health, Institute for Health Sciences, Queen's University Belfast, Belfast, Northern Ireland., Verbeeck J; Belgian Cancer Registry, Brussels, Belgium., Van Hemelrijck M; Translational Oncology and Urology Research, King's College London, London, UK.
Publikováno v:
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2019 Aug; Vol. 33 (4), pp. 479-499. Date of Electronic Publication: 2019 Mar 25.
Autor:
Matthes KL; Division of Chronic Disease Epidemiology, Institute for Epidemiology, Biostatistics and Prevention, University of Zurich, Zurich, Switzerland; Cancer Registry Zurich and Zug, University Hospital Zurich, Zurich, Switzerland. Electronic address: katarinaluise.matthes@usz.ch., Pestoni G; Division of Chronic Disease Epidemiology, Institute for Epidemiology, Biostatistics and Prevention, University of Zurich, Zurich, Switzerland; Cancer Registry Zurich and Zug, University Hospital Zurich, Zurich, Switzerland., Korol D; Cancer Registry Zurich and Zug, University Hospital Zurich, Zurich, Switzerland., Van Hemelrijck M; Division of Cancer Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, United Kingdom., Rohrmann S; Division of Chronic Disease Epidemiology, Institute for Epidemiology, Biostatistics and Prevention, University of Zurich, Zurich, Switzerland; Cancer Registry Zurich and Zug, University Hospital Zurich, Zurich, Switzerland.
Publikováno v:
Urologic oncology [Urol Oncol] 2018 Jun; Vol. 36 (6), pp. 309.e15-309.e23. Date of Electronic Publication: 2018 Mar 22.
Autor:
Thomsen FB; Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address: thomsen.frederik@gmail.com., Sandin F; Regional Cancer Centre Uppsala Örebro, Uppsala University Hospital, Uppsala, Sweden., Garmo H; Regional Cancer Centre Uppsala Örebro, Uppsala University Hospital, Uppsala, Sweden; Cancer Epidemiology Group, School of Medicine, Division of Cancer Studies, King's College London, London, UK., Lissbrant IF; Department of Oncology, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Ahlgren G; Department of Urology, SUS Malmö, Region Skåne, Malmö, Sweden., Van Hemelrijck M; Cancer Epidemiology Group, School of Medicine, Division of Cancer Studies, King's College London, London, UK; Epidemiology Unit, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Adolfsson J; CLINTEC-department, Karolinska Institutet, Stockholm, Sweden., Robinson D; Department of Urology, Ryhov Hospital, Jönköping, Sweden., Stattin P; Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University Hospital, Umeå, Sweden.
Publikováno v:
European urology [Eur Urol] 2017 Dec; Vol. 72 (6), pp. 920-928. Date of Electronic Publication: 2017 Jul 12.
Autor:
Walldius G; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine., Malmström H; Unit of Epidemiology, Institute of Environmental Medicine., Jungner I; Unit of Epidemiology, Institute of Environmental Medicine., de Faire U; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine., Lambe M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Regional Cancer Centre, Uppsala, Sweden., Van Hemelrijck M; Kings College London, Cancer Epidemiology Group, London, UK., Hammar N; Unit of Epidemiology, Institute of Environmental Medicine.; Medical Evidence & Observational Research, AstraZeneca, Mölndal, Sweden.
Publikováno v:
International journal of epidemiology [Int J Epidemiol] 2017 Aug 01; Vol. 46 (4), pp. 1103-1103i.
Autor:
Rohrmann S; Division of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute (EPBI), University of Zurich, Zurich, UK. Electronic address: sabine.rohrmann@uzh.ch., Garmo H; Cancer Epidemiology Unit, Division of Cancer Studies, Kings College London, London, UK; Regional Cancer Centre, Uppsala University Hospital, Uppsala, Sweden., Malmström H; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Hammar N; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; AstraZeneca, Södertälje, Sweden., Jungner I; Department of Medicine, Clinical Epidemiological Unit, Karolinska Institutet and CALAB Research, Stockholm, Sweden., Walldius G; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Van Hemelrijck M; Cancer Epidemiology Unit, Division of Cancer Studies, Kings College London, London, UK.
Publikováno v:
Atherosclerosis [Atherosclerosis] 2016 Aug; Vol. 251, pp. 85-93. Date of Electronic Publication: 2016 Jun 02.
Autor:
Nderitu P; Department of Oncology, Guy's Hospital, London, UK., Van Hemelrijck M; Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London, UK., Ashworth M; Department of Primary Care and Public Health Sciences, King's College London, London, UK., Mathur R; Centre for Primary Care and Public Health, Queen Mary University of London, London, UK., Hull S; Centre for Primary Care and Public Health, Queen Mary University of London, London, UK., Dudek A; Department of Oncology, Guy's Hospital, London, UK., Chowdhury S; Department of Oncology, Guy's Hospital, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2016 Jul 12; Vol. 6 (7), pp. e011356. Date of Electronic Publication: 2016 Jul 12.
Autor:
Melvin JC; Cancer Epidemiology Group, Division of Cancer Studies, School of Medicine, King's College London, London, UK., Garmo H; Cancer Epidemiology Group, Division of Cancer Studies, School of Medicine, King's College London, London, UK.; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden., Daniel R; Centre for Statistical Methodology and Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK., Shanmugalingam T; Cancer Epidemiology Group, Division of Cancer Studies, School of Medicine, King's College London, London, UK., Stattin P; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden., Häggström C; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden., Rudman S; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Holmberg L; Cancer Epidemiology Group, Division of Cancer Studies, School of Medicine, King's College London, London, UK.; Regional Cancer Centre, Uppsala/Örebro, Sweden.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Regional Oncologic Centre, Uppsala University, Uppsala, Sweden., Van Hemelrijck M; Cancer Epidemiology Group, Division of Cancer Studies, School of Medicine, King's College London, London, UK.
Publikováno v:
BJU international [BJU Int] 2015 Nov; Vol. 116 (5), pp. 681-3. Date of Electronic Publication: 2015 May 13.